4. Patients previously entered into a therapeutic trial during or after neoadjuvant chemotherapy where experimental therapy is continued post-surgery. Patients involved in clinical trials involving experimental drugs prior to primary standard treatment (i.e. window of opportunity trials) can be considered for entry into c-TRAK TN.